ClinicalTrialsFinder

Hepatic Impairment (HI) Clinical Trials in San Antonio, Texas

1 recruitingSan Antonio, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

Hepatic Impairment (HI)
Merck Sharp & Dohme LLC32 enrolled3 locationsNCT06442436